Brain E - Search Results

1

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.

Monnet I, de CH, Soulié P, Saltiel-Voisin S, Bekradda M, Saltiel JC, Brain E, Rixe O, Yataghene Y, Misset JL, Cvitkovic E. Monnet I, et al. Among authors: brain e. Ann Oncol. 2002 Jan;13(1):103-7. doi: 10.1093/annonc/mdf006. Ann Oncol. 2002. PMID: 11863089 Free article. Clinical Trial.

2

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.

Le Cesne A, Antoine E, Spielmann M, Le Chevalier T, Brain E, Toussaint C, Janin N, Kayitalire L, Fontaine F, Genin J, et al. Le Cesne A, et al. Among authors: brain e. J Clin Oncol. 1995 Jul;13(7):1600-8. doi: 10.1200/JCO.1995.13.7.1600. J Clin Oncol. 1995. PMID: 7541449 Clinical Trial.

3

[High-dose methotrexate and cerebral neurotoxicity. Apropos of a case of arachnoiditis].

Brain E, Alexandre J, Minozzi C, Misset JL. Brain E, et al. Presse Med. 1997 Mar 1;26(6):265-8. Presse Med. 1997. PMID: 9122123 French.

4

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

Brain E, Garrino C, Misset JL, Carbonero IG, Itzhaki M, Cvitkovic E, Goldschmidt E, Burki F, Regensberg C, Pappo E, Hagipantelli R, Musset M. Brain E, et al. Br J Cancer. 1997;75(9):1360-7. doi: 10.1038/bjc.1997.230. Br J Cancer. 1997. PMID: 9155059 Free PMC article.

5

Clinical and pathological response to primary chemotherapy in operable breast cancer.

Chollet P, Charrier S, Brain E, Curé H, van Praagh I, Feillel V, de Latour M, Dauplat J, Misset JL, Ferrière JP. Chollet P, et al. Among authors: brain e. Eur J Cancer. 1997 May;33(6):862-6. doi: 10.1016/s0959-8049(97)00038-5. Eur J Cancer. 1997. PMID: 9291806

6

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.

Soulié P, Bensmaïne A, Garrino C, Chollet P, Brain E, Fereres M, Jasmin C, Musset M, Misset JL, Cvitkovic E. Soulié P, et al. Among authors: brain e. Eur J Cancer. 1997 Aug;33(9):1400-6. doi: 10.1016/s0959-8049(97)00122-6. Eur J Cancer. 1997. PMID: 9337681 Clinical Trial.

7

Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer.

Soulié P, Trandafir L, Taamma A, Lokiec F, Brain E, Delord JP, Mita A, Vannetzel JM, Cvitkovic E, Misset JL. Soulié P, et al. Among authors: brain e. Anticancer Drugs. 1997 Sep;8(8):763-6. doi: 10.1097/00001813-199709000-00005. Anticancer Drugs. 1997. PMID: 9396620 Clinical Trial.

8

Primary chemotherapy or hormonotherapy for patients with breast cancer.

Brain EG, Misset JL, Rouëss J. Brain EG, et al. Cancer Treat Rev. 1999 Aug;25(4):187-97. doi: 10.1053/ctrv.1998.0118. Cancer Treat Rev. 1999. PMID: 10448127 Review.

9

Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.

Soulié P, Garrino C, Bensmaïne MA, Bekradda M, Brain E, Di Palma M, Goupil A, Misset JL, Cvitkovic E. Soulié P, et al. Among authors: brain e. J Cancer Res Clin Oncol. 1999 Dec;125(12):707-11. doi: 10.1007/s004320050338. J Cancer Res Clin Oncol. 1999. PMID: 10592105 Clinical Trial.

10

Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study.

van Kesteren C, Cvitkovic E, Taamma A, López-Lázaro L, Jimeno JM, Guzman C, Math t RA, Schellens JH, Misset JL, Brain E, Hillebrand MJ, Rosing H, Beijnen JH. van Kesteren C, et al. Among authors: brain e. Clin Cancer Res. 2000 Dec;6(12):4725-32. Clin Cancer Res. 2000. PMID: 11156226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters